{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:22:35Z","timestamp":1787318555988,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31DA035567"],"award-info":[{"award-number":["F31DA035567"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA033312"],"award-info":[{"award-number":["K12DA033312"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001862"],"award-info":[{"award-number":["KL2TR001862"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U10AA013566"],"award-info":[{"award-number":["U10AA013566"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01AA020790"],"award-info":[{"award-number":["U01AA020790"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U24AA020794"],"award-info":[{"award-number":["U24AA020794"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P30MH062294"],"award-info":[{"award-number":["P30MH062294"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.drugalcdep.2018.05.033","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:49:25Z","timestamp":1533559765000},"page":"371-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-8505","authenticated-orcid":false,"given":"Julie R.","family":"Gaither","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsha","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Kerns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. (5)","key":"10.1016\/j.drugalcdep.2018.05.033_bib0005","doi-asserted-by":"crossref","first-page":"S668","DOI":"10.2105\/AJPH.2015.302892","article-title":"Racial and ethnic disparities in services and the patient protection and affordable care act","volume":"105","author":"Abdus","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0010","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMsa044464","article-title":"Who is at greatest risk for receiving poor-quality health care?","volume":"354","author":"Asch","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-6296(02)00098-X","article-title":"Prejudice, clinical uncertainty and stereotyping as sources of health disparities","volume":"22","author":"Balsa","year":"2003","journal-title":"J. Health Econ."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1370\/afm.1242","article-title":"Racial differences in primary care opioid risk reduction strategies","volume":"9","author":"Becker","year":"2011","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0025","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.pain.2013.02.031","article-title":"Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review","volume":"154","author":"Becker","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1521-0391.2013.12109.x","article-title":"Racial\/ethnic differences in report of drug testing practices at the workplace level in the U.S","volume":"23","author":"Becker","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0035","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jpain.2008.06.002","article-title":"Trends in use of opioids by noncancer pain type 2000\u20132005 among ARKANSAS medicaid and health core enrollees: results from the TROUP study","volume":"9","author":"Braden","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpain.2013.12.010","article-title":"Racial differences in prescription of opioid analgesics for chronic noncancer pain in a national sample of veterans","volume":"15","author":"Burgess","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0045","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJMsr1601307","article-title":"A proactive response to prescription opioid abuse","volume":"374","author":"Califf","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0050","series-title":"Prescription Opioid-related Overdose Deaths","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11606-012-2189-z","article-title":"Receipt of opioid analgesics by HIV-infected and uninfected patients","volume":"28","author":"Edelman","year":"2013","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0075","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jpain.2014.08.004","article-title":"Guideline-concordant management of opioid therapy among Human Immunodeficiency Virus (HIV)-infected and uninfected veterans","volume":"15","author":"Gaither","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11606-015-3571-4","article-title":"The association between receipt of guideline-concordant long-term opioid therapy and all-cause mortality","volume":"31","author":"Gaither","year":"2016","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0085","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/ADM.0000000000000255","article-title":"The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality","volume":"10","author":"Gaither","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0090","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/1475-6773.12031","article-title":"Disparities in completion of substance abuse treatment between and within racial and ethnic groups","volume":"48","author":"Guerrero","year":"2013","journal-title":"Health Serv. Res."},{"issue":"8 Suppl 2","key":"10.1016\/j.drugalcdep.2018.05.033_bib0095","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.mlr.0000223741.02074.66","article-title":"Veterans Aging Cohort Study (VACS): overview and description","volume":"44","author":"Justice","year":"2006","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1468-1293.2009.00757.x","article-title":"Towards a combined prognostic index for survival in HIV infection: the role of\u2019 non-HIV\u2019 biomarkers","volume":"11","author":"Justice","year":"2010","journal-title":"HIV Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","article-title":"Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: A North American cross cohort analysis","volume":"62","author":"Justice","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Korff","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.36076\/ppj.2011\/14\/91","article-title":"A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain","volume":"14","author":"Manchikanti","year":"2011","journal-title":"Pain Phys."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsat.2015.12.007","article-title":"Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances","volume":"63","author":"Mennis","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0125","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014 United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0130","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014 United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addbeh.2015.04.006","article-title":"Evaluating racial disparity in referral source and successful completion of substance abuse treatment","volume":"48","author":"Sahker","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0140","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jama.2012.234","article-title":"Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan","volume":"307","author":"Seal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0031-1298595","article-title":"Assessing bias: The importance of considering confounding","volume":"3","author":"Skelly","year":"2012","journal-title":"Evid. Based Spine Care J."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0150","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-152-11-201006010-00004","article-title":"Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain","volume":"152","author":"Starrels","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0155","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11606-011-1648-2","article-title":"Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain","volume":"26","author":"Starrels","year":"2011","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0160","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11606-012-2165-7","article-title":"They don\u2019t know what they don\u2019t know: internal medicine residents\u2019 knowledge and confidence in urine drug test interpretation for patients with chronic pain","volume":"27","author":"Starrels","year":"2012","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08897077.2015.1129391","article-title":"When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: a qualitative study of HIV treatment providers","volume":"37","author":"Starrels","year":"2016","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0170","series-title":"Reports and Detailed Tables From the 2016 National Survey on Drug Use and Health (NSDUH)","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","article-title":"An internationally generalizable risk index for mortality after one year of antiretroviral therapy","volume":"27","author":"Tate","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0180","series-title":"Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain","author":"US Department of Veterans Affairs","year":"2003"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0185","series-title":"Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain","author":"US Department of Veterans Affairs","year":"2010"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0190","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2011.401","article-title":"Characteristics of opioid prescriptions in 2009","volume":"305","author":"Volkow","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.05.033_bib0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin. J. Pain"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618303855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618303855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:00:38Z","timestamp":1759827638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618303855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":39,"alternative-id":["S0376871618303855"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.05.033","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}